257 related articles for article (PubMed ID: 25201005)
21. Splenic marginal zone lymphoma: current knowledge and future directions.
Thieblemont C; Davi F; Noguera ME; Brière J; Bertoni F; Zucca E; Traverse-Glehen A; Felman P; Berger F; Salles G; Coiffier B
Oncology (Williston Park); 2012 Feb; 26(2):194-202. PubMed ID: 22489356
[TBL] [Abstract][Full Text] [Related]
22. Splenic marginal zone lymphoma associated with hepatitis B virus infection, remission after viral treatment, and splenectomy: A case report and review of the literature.
Ababou M; Mahtat EM; Jennane S; Elmaaroufi H; Mikdame M; Doghmi K
Hematol Oncol Stem Cell Ther; 2021 Jun; 14(2):153-155. PubMed ID: 31306619
[TBL] [Abstract][Full Text] [Related]
23. Risk adapted approach: How to treat splenic marginal zone lymphoma in resource-poor settings? - The real-life experience of a Brazilian cancer treatment center.
de Pádua Covas Lage LA; Dos Santos FFC; Levy D; Moreira FR; Couto SCF; Culler HF; de Oliveira Costa R; Rocha V; Pereira J
BMC Cancer; 2020 Aug; 20(1):717. PubMed ID: 32746790
[TBL] [Abstract][Full Text] [Related]
24. Case records of the Massachusetts General Hospital. Case 39-2008. A 51-year-old woman with splenomegaly and anemia.
Abramson JS; Chatterji M; Rahemtullah A
N Engl J Med; 2008 Dec; 359(25):2707-18. PubMed ID: 19092156
[No Abstract] [Full Text] [Related]
25. Clinicopathological features of splenic tumours of lymphoid tissue.
Chen DB; Shen DH; Yang SM; Fang XZ
Pathol Res Pract; 2018 Dec; 214(12):1952-1958. PubMed ID: 30087035
[TBL] [Abstract][Full Text] [Related]
26. Should rituximab replace splenectomy in the management of splenic marginal zone lymphoma?
Kalpadakis C; Pangalis GA; Angelopoulou MK; Sachanas S; Vassilakopoulos TP
Best Pract Res Clin Haematol; 2018 Mar; 31(1):65-72. PubMed ID: 29452668
[TBL] [Abstract][Full Text] [Related]
27. [Splenic marginal zone lymphoma complicated by cold agglutinin disease].
Ochi K; Yokoyama K; Ohno N; Ota Y; Tojo A
Rinsho Ketsueki; 2017; 58(2):132-137. PubMed ID: 28321090
[TBL] [Abstract][Full Text] [Related]
28. Successful treatment of catastrophic antiphospholipid antibody syndrome (CAPS) associated with splenic marginal-zone lymphoma with low-molecular weight heparin, rituximab and bendamustine.
Manner H; Jung B; Tonassi L; Hackenberg U; Plum N; Josten KM; Kirchmaier CM; Frickhofen N
Am J Med Sci; 2008 May; 335(5):394-7. PubMed ID: 18480659
[TBL] [Abstract][Full Text] [Related]
29. Survival outcomes with and without splenectomy in splenic marginal zone lymphoma.
Olszewski AJ
Am J Hematol; 2012 Nov; 87(11):E119-22. PubMed ID: 22887176
[TBL] [Abstract][Full Text] [Related]
30. Laparoscopic splenectomy for treatment of splenic marginal zone lymphoma.
Wu Z; Zhou J; Wang X; Li YB; Niu T; Peng B
World J Gastroenterol; 2013 Jun; 19(24):3854-60. PubMed ID: 23840125
[TBL] [Abstract][Full Text] [Related]
31. Classical Hodgkin lymphoma concurrently evolving in a patient with marginal zone B-cell lymphoma of the spleen.
Harada S; Kalla H; Balasubramanian M; Brodsky I; Gladstone D; Hou JS
Ann Diagn Pathol; 2008 Jun; 12(3):212-6. PubMed ID: 18486899
[TBL] [Abstract][Full Text] [Related]
32. Splenic B-cell lymphomas with more than 55% prolymphocytes in blood: evidence for prolymphocytoid transformation.
Hoehn D; Miranda RN; Kanagal-Shamanna R; Lin P; Medeiros LJ
Hum Pathol; 2012 Nov; 43(11):1828-38. PubMed ID: 22520947
[TBL] [Abstract][Full Text] [Related]
33. Splenic Marginal Zone Lymphoma with Acquired von Willebrand Syndrome Diagnosed via Splenic Bleeding.
Komeno Y; Shibuya N; Uryu H; Yamada H; Toda T; Shibasaki M; Kunishima S; Iihara K; Ryu T
Intern Med; 2017; 56(5):557-562. PubMed ID: 28250305
[TBL] [Abstract][Full Text] [Related]
34. [Clinical characteristics of splenic marginal zone lymphoma with abnormal complete blood count].
Yang SM; Jiang Q; Jiang B; Chen DB; Wang J; Jiang H; Lu J; Lu XJ; Bao L; Shi HX; Liu YR; Huang XJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Feb; 21(1):87-94. PubMed ID: 23484698
[TBL] [Abstract][Full Text] [Related]
35. First-line treatment with bendamustine and rituximab, in patients with intermediate-/high-risk splenic marginal zone lymphomas.
Castelli R; Bergamaschini L; Deliliers GL
Med Oncol; 2017 Dec; 35(2):15. PubMed ID: 29288421
[TBL] [Abstract][Full Text] [Related]
36. Bone marrow histopathology in the diagnostic evaluation of splenic marginal-zone and splenic diffuse red pulp small B-cell lymphoma: a reliable substitute for spleen histopathology?
Ponzoni M; Kanellis G; Pouliou E; Baliakas P; Scarfò L; Ferreri AJ; Doglioni C; Bikos V; Dagklis A; Anagnostopoulos A; Ghia P; Stamatopoulos K; Papadaki T
Am J Surg Pathol; 2012 Nov; 36(11):1609-18. PubMed ID: 23073320
[TBL] [Abstract][Full Text] [Related]
37. State-of-the-art therapeutics: marginal-zone lymphoma.
Bertoni F; Zucca E
J Clin Oncol; 2005 Sep; 23(26):6415-20. PubMed ID: 16155028
[TBL] [Abstract][Full Text] [Related]
38. Interference from lupus anticoagulant on von Willebrand factor measurement in splenic marginal zone lymphoma: a case report.
Vinholt PJ; Nybo M
Blood Coagul Fibrinolysis; 2015 Jun; 26(4):454-7. PubMed ID: 25485787
[TBL] [Abstract][Full Text] [Related]
39. Outcomes in patients with splenic marginal zone lymphoma and marginal zone lymphoma treated with rituximab with or without chemotherapy or chemotherapy alone.
Tsimberidou AM; Catovsky D; Schlette E; O'Brien S; Wierda WG; Kantarjian H; Garcia-Manero G; Wen S; Do KA; Lerner S; Keating MJ
Cancer; 2006 Jul; 107(1):125-35. PubMed ID: 16700034
[TBL] [Abstract][Full Text] [Related]
40. Rituximab monotherapy is highly effective in splenic marginal zone lymphoma.
Kalpadakis C; Pangalis GA; Dimopoulou MN; Vassilakopoulos TP; Kyrtsonis MC; Korkolopoulou P; Kontopidou FN; Siakantaris MP; Dimitriadou EM; Kokoris SI; Tsaftaridis P; Plata E; Angelopoulou MK
Hematol Oncol; 2007 Sep; 25(3):127-31. PubMed ID: 17514771
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
